17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2
and its subsidiary for the third quarter ended September 30, 2019 which the details are as follows: Unit: million Baht For 3-month period (July-Sep) 2019 2018 Change % Increase (Decrease) Revenue from
of income generating assets from the EBT of UE since 16 March 2018, whose revenue contribution this quarter amounted to THB 119mn, being partially offset by (iii) a decrease of 25.8% YoY or THB 29mn of
price in order to no loss from procurement and stock inventory The company had sales volume decrease for the 6 months ended June 30, 2019 as result to the costs of goods and services decreased amount of
. Resolved to propose the Shareholders’ Meeting to consider and approve the decrease of the Company registered capital and the amendment of clause 4 of the Company’s Memorandum of Association regarding
revenue from the core business in 2Q2020 was Bt666.61mn, decreasing 17.1% YoY, mainly from a decrease of the middle-to-low income population’s purchasing power due to drought and Covid-19 pandemic, as well
in Q2/2018 decreased THB 1.19 million in total in the six-month period in Q2/2018 compared to previous year from the adjustment in customer base in Singapore and the Philippines, resulting in the drop
of recovery in Q3/2018 after the sluggish economy in the first half-year resulting in the drop in orders in Q1-2/2018. Towards the end of the year 2016, the Company invested in a new factory building
and indirectly, would drop from 99.99 percent to 79.52 percent. Therefore, the IFA views that the disposal of WIE shares and the acquisition of NAUTIC shares constitutes consideration for the sale of